1-3 of 3
Susumu Suzuki, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synergistic Effect of Venetoclax for Antibody Dependent Cell Cytotoxicity By Daratumumab

Ayano Nakamura, MD, Susumu Suzuki, PhD, Masao Seto, MD PhD, Souichi Takasugi, MD, Jo Kanasugi, MD, Ichiro Hanamura, MD PhD, Ryuzo Ueda, MD PhD, Akiyoshi Takami, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-134486
Published: 2020
Journal Articles

ABT-199 (venetoclax) Synergizes Cytotoxicity of Cytotoxic T-Cell (CTL) to B-Cell Lymphomas

Satsuki Murakami, MD, Susumu Suzuki, PhD, Ichiro Hanamura, MD PhD, Kazuhiro Yoshikawa, PhD, Ryuzo Ueda, MD PhD, Akiyoshi Takami, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5154.
https://doi.org/10.1182/blood-2018-99-117471
Published: 2018
Journal Articles

Monitoring of Adult T-Cell Leukemia-Lymphoma Cells in Patients Receiving Mogamulizumab, a Humanized Anti-CCR4 Monoclonal Antibody, Using T-Cell Receptor Repertoire Analysis

Masato Saito, Takashi Ishida, MD PhD, Itaru Urakawa, PhD, Toshihiko Ishii, Asahi Ito, MD PhD, Ayako Masaki, MD PhD, Susumu Suzuki, PhD, Shigeru Kusumoto, MD PhD, Hirokazu Komatsu, MD PhD, Hiroshi Inagaki, MD PhD, Takeshi Takahashi, PhD, Ryuzo Ueda, MD PhD, Shinsuke Iida, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1744.
https://doi.org/10.1182/blood.V128.22.1744.1744
Published: 2016